Efforts Continue to Introduce Immunotherapy Into Earlier NSCLC Settings – OncLive
OncLive |
Efforts Continue to Introduce Immunotherapy Into Earlier NSCLC Settings
OncLive Investigators hope that the addition of immunotherapy will kill additional tumor cells still present even after these traditional treatment methods. Aside from this trial, researchers are also exploring PD-1/CTLA-4 combinations as first-line treatment … |
